RNTX (RNTX) reported R&D of $3.07M in Q1 2026.

How has RNTX's R&D changed year-over-year?

RNTX's R&D increased by 0.6% year-over-year, from $3.05M to $3.07M.

What is the long-term trend for RNTX's R&D?

Over 4 years (2021 to 2025), RNTX's R&D has grown at a -10.3% compound annual growth rate (CAGR), from $17.01M to $11.03M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

RNTX RNTX R&D

R&D at other companies

Bristol-Myers SquibbBMY

$2.65B+17.4%

CTO

Citius Oncology, Inc.CTOR

$1.08M-65.6%

Ethos Technologies, Inc. LIFE

$7.32M-38.1%

Gyre Therapeutics, Inc.GYRE

$6.74M+118%

Syndax PharmaceuticalsSNDX

$58.85M-4.5%

LQD

Liquidia CorporationLQDA

$12.57M+80.5%

Segments

By product

See full

Clinical Operation Activities$1.96M+191%

CMC Activities$520K-7.1%

Employee Related Expenses$500K-19.6%

Facilities And Other Expenses$25K+56.3%

Preclinical Study Costs$0-100%

Professional Fees For Services$0-100%

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M+6.8%

Net income-$5.8M-6.1%

EPS (diluted)-$0.19+24.0%

Balance sheet

See full

Cash & equivalents$4.4M-40.2%

Total debt$48.0K0.0%

Total equity$6.9M-63.0%

Total assets$26.3M-54.4%

Cash flow

See full

Operating cash flow-$3.4M+44.6%

CapEx-—

Free cash flow-$6.3M—

Valuation

See full

Market cap$88.96M+164%

Returns & leverage

See full

Return on equity-123.3%+86.1pp

Debt / equity0×0.0×

Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is RNTX's R&D?: RNTX (RNTX) reported R&D of $3.07M in Q1 2026.
How has RNTX's R&D changed year-over-year?: RNTX's R&D increased by 0.6% year-over-year, from $3.05M to $3.07M.
What is the long-term trend for RNTX's R&D?: Over 4 years (2021 to 2025), RNTX's R&D has grown at a -10.3% compound annual growth rate (CAGR), from $17.01M to $11.03M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.